Non-high-density lipoprotein cholesterol versus low-density lipoprotein cholesterol as a risk factor for a first nonfatal myocardial infarction

被引:45
|
作者
Farwell, WR
Sesso, HD [1 ]
Buring, JE
Gaziano, JM
机构
[1] Brigham & Womens Hosp, Vet Affairs Med Ctr, Dept Med, Div Aging, Boston, MA 02115 USA
[2] Brigham & Womens Hosp, Vet Affairs Med Ctr, Dept Med, Div Prevent Med, Boston, MA 02115 USA
[3] Brigham & Womens Hosp, Vet Affairs Med Ctr, Dept Med, Div Cardiovasc, Boston, MA 02115 USA
[4] Harvard Univ, Sch Med, Boston, MA 02115 USA
[5] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA
[6] Harvard Univ, Sch Med, Dept Ambulatorio Care & Prevent, Boston, MA 02115 USA
来源
AMERICAN JOURNAL OF CARDIOLOGY | 2005年 / 96卷 / 08期
关键词
D O I
10.1016/j.amjcard.2005.06.044
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Low-density lipoprotein (LDL) cholesterol is the primary lipid parameter targeted to prevent myocardial infarction. Alternatively, non-high-density lipoprotein (HDL) cholesterol includes LDL cholesterol and other atherogenic particles but does not require a fasting sample. Non-HDL cholesterol and LDL cholesterol as predictors of first nonfatal myocardial infarction were compared in 303 patients and 297 controls matched for age, gender, and community within the Boston Area Health Study. Patients were white men or women aged <76 years living in the Boston area, without a history of myocardial infarction or angina pectoris, in whom symptoms of confirmed myocardial infarction began during the 24 hours before admission. After multivariate adjustment for coronary risk factors in unmatched analyses, the corresponding odds ratios (ORs) of a first nonfatal myocardial infarction for non-HDL cholesterol in the second, third, and fourth quartiles were 1.83 (95% confidence interval [CI] 1.07 to 3.14), 2.07 (95% CI 1.23 to 3.49), and 2.33 (95% CI 1.39 to 3.90) (p trend <0.01). For LDL cholesterol, the ORs were 1.10 (95% CI 0.67 to 1.81), 0.87 (95% CI 0.52 to 1.46), and 1.45 (95% CI 0.90 to 2.35) (p trend = 0.16). Including HDL cholesterol in the model increased the ORs and strengthened the test for a trend for LDL cholesterol, whereas the ORs were decreased and the test for a trend was weakened for non-HDL cholesterol. In conclusion, given that non-HDL cholesterol accounts for LDL cholesterol plus other atherogenic particles but does not require a fasting sample, this study suggests that non-HDL cholesterol may be at least as useful as LDL cholesterol to initially screen patients for risk of a first nonfatal myocardial infarction. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:1129 / 1134
页数:6
相关论文
共 50 条
  • [21] Total cholesterol, low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol in atherosclerosis cardiovascular disease and cancer in Chinese male
    Guan, X. M.
    Yang, X. L.
    Han, X.
    Yang, Y. H.
    Liu, Y.
    Li, H. H.
    Zhan, S. Y.
    Wu, S. L.
    Xia, Y. L.
    EUROPEAN HEART JOURNAL, 2017, 38 : 724 - 725
  • [22] Interaction of lipoprotein(a) with low-density lipoprotein cholesterol on first incident acute myocardial infarction
    Hu, Yong
    Tao, Jian-Ying
    Cai, Dong-Ping
    He, Yong-Ming
    CLINICA CHIMICA ACTA, 2020, 501 : 1 - 5
  • [23] Low-Density Lipoprotein Cholesterol, Non-High-Density Lipoprotein Cholesterol, Triglycerides, and Apolipoprotein B and Cardiovascular Risk in Patients With Manifest Arterial Disease
    van den Berg, M. Johanneke
    van der Graaf, Yolanda
    de Borst, Gert Jan
    Kappelle, L. Jaap
    Nathoe, Hendrik M.
    Visseren, Frank L. J.
    AMERICAN JOURNAL OF CARDIOLOGY, 2016, 118 (06): : 804 - 810
  • [24] Physiological Bases for the Superiority of Apolipoprotein B Over Low-Density Lipoprotein Cholesterol and Non-High-Density Lipoprotein Cholesterol as a Marker of Cardiovascular Risk
    Glavinovic, Tamara
    Thanassoulis, George
    de Graaf, Jacqueline
    Couture, Patrick
    Hegele, Robert A.
    Sniderman, Allan D.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2022, 11 (20):
  • [25] Non-high-density lipoprotein cholesterol predicts nonfatal recurrent myocardial infarction in patients with ST segment elevation myocardial infarction
    Gao, Ming
    Zheng, Yang
    Zhang, Weihua
    Cheng, Yi
    Wang, Lin
    Qin, Ling
    LIPIDS IN HEALTH AND DISEASE, 2017, 16 : 1 - 8
  • [26] Non-high-density lipoprotein cholesterol predicts nonfatal recurrent myocardial infarction in patients with ST segment elevation myocardial infarction
    Ming Gao
    Yang Zheng
    Weihua Zhang
    Yi Cheng
    Lin Wang
    Ling Qin
    Lipids in Health and Disease, 16
  • [27] Assessment of reaching goal in patients with combined hyperlipidemia: Low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, or apolipoprotein B
    Stein, EA
    Sniderman, A
    Laskarzewski, P
    AMERICAN JOURNAL OF CARDIOLOGY, 2005, 96 (9A): : 36K - 43K
  • [28] Association of total cholesterol, low-density lipoprotein cholesterol, and non-high-density lipoprotein cholesterol with atherosclerotic cardiovascular disease and cancer in a Chinese male population
    Guan, Xu-Min
    Wu, Shou-Ling
    Yang, Xiao-Lei
    Han, Xu
    Yang, Yi-Heng
    Li, Xin-Tao
    Bin Waleed, Khalid
    Du, Yue
    Zhan, Si-Yan
    Liu, Ying
    Li, Hui-Hua
    Xia, Yun-Long
    INTERNATIONAL JOURNAL OF CANCER, 2018, 142 (06) : 1209 - 1217
  • [29] Non-high-density lipoprotein cholesterol is the best discriminator of myocardial infarction in young individuals
    Rallidis, L
    Pitsavos, C
    Panagiotakos, C
    Foulidis, V
    Sinos, L
    Chrysochoou, C
    Stefanadis, C
    Kremastinos, D
    CIRCULATION, 2004, 110 (17) : 469 - 469
  • [30] Apolipoprotein B vs Low-Density Lipoprotein Cholesterol and Non-High-Density Lipoprotein Cholesterol as the Primary Measure of Apolipoprotein B Lipoprotein-Related Risk The Debate Is Over
    Sniderman, Allan D.
    Navar, Ann Marie
    Thanassoulis, George
    JAMA CARDIOLOGY, 2022, 7 (03) : 257 - 258